SARS-CoV-2 Genetic Diversity and Evolution

Like other coronaviruses, SARS-CoV-2 is evolving. The genomic diversity of SARS-CoV-2 strains in different countries is consistent with multiple introductions of the virus to different locations, seeding local transmission events. The papers in this feed report latest research into genetic variation and phylogeny of this highly successful virus.

January 16, 2022
Preprint
Open Access

Resilient T cell responses to B.1.1.529 (Omicron) SARS-CoV-2 variant

MedRxiv : the Preprint Server for Health Sciences
M. JergovicJanko Nikolich-Zugich
January 16, 2022
Comment / Editorial

COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop.

ALTEX
Laure-Alix ClerbauxClemens Wittwehr
January 16, 2022
Review

The Inhibition of RNA Viruses by Amaryllidaceae Alkaloids: Opportunities for the Development of Broad-Spectrum Anti-Coronavirus Drugs.

Chemistry, an Asian Journal
Shen TanLorenzo V White
January 16, 2022

Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift.

Journal of Medical Virology
Tao LiYouchun Wang
January 16, 2022

Automatic system for high-throughput and high-sensitivity diagnosis of SARS-CoV-2.

Bioprocess and Biosystems Engineering
Jun LuXiao Zhang
January 16, 2022

Targeted vaccination and the speed of SARS-CoV-2 adaptation.

Proceedings of the National Academy of Sciences of the United States of America
Sylvain Gandon, Sébastien Lion
January 16, 2022

Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved?

Tropical Diseases, Travel Medicine and Vaccines
Héctor Serrano-CollSalim Mattar
January 15, 2022
Preprint
Open Access

Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease

MedRxiv : the Preprint Server for Health Sciences
Anna C RiddellT. Cutino-Moguel
January 15, 2022

Molecular Beacons Allow Specific RT-LAMP Detection of B.1.1.7 Variant SARS-CoV-2.

Journal of Biomolecular Techniques : JBT
Scott Sherrill-MixFrederic D Bushman
January 15, 2022

Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Nabin K ShresthaSteven M Gordon
January 15, 2022

Immunity evasion: consequence of the N501Y mutation of the SARS-CoV-2 spike glycoprotein.

Journal, Genetic Engineering & Biotechnology
Henrietta Onyinye UzoetoOlanrewaju Ayodeji Durojaye
January 15, 2022

Plasma Neutralization of the SARS-CoV-2 Omicron Variant.

The New England Journal of Medicine
Fabian SchmidtPaul D Bieniasz

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

© 2022 Meta ULC. All rights reserved
/feed-previews/sars-cov-2-genetic-diversity-and/a64a85ad-3b64-4f79-a9cc-f9ada9a9c283